Related Experiment Videos
Myocardial viability
1Heart Institute, Good Samaritan Hospital, Los Angeles, CA 90017, USA.
Insights
Differentiating causes of left ventricular dysfunction, such as myocardial stunning, ischemia, or hibernation, is crucial for predicting patient outcomes in coronary artery disease. Dobutamine stress testing helps identify reversible dysfunction and guides appropriate treatment strategies.
Area of Science:
- Cardiology
- Nuclear Cardiology
- Cardiovascular Imaging
Background:
- Left ventricular function is a critical prognostic indicator in patients with coronary artery disease.
- Myocardial dysfunction can manifest as acute ischemia, stunning (postischemic dysfunction), or hibernation, often requiring differentiation for effective management.
- Reversible myocardial dysfunction is a key focus, with stunning characterized by dysfunction despite normal perfusion and spontaneous recovery.
Purpose of the Study:
- To differentiate between various causes of reversible myocardial dysfunction in patients with coronary artery disease.
- To evaluate the utility of dobutamine stress testing in identifying the underlying mechanisms of ventricular dysfunction.
- To underscore the importance of distinguishing between stunned, hibernating/ischemic, and nonviable myocardium for prognosis and therapeutic decisions.
Main Methods:
- Assessment of myocardial viability using metabolic tracers like thallium (thallous chloride TI 201) or fludeoxyglucose F 18.
- Evaluation of contractile reserve in dysfunctional regions through dobutamine stress testing.
- Analysis of the dose-dependent response of ventricular segments to dobutamine infusion to infer the mechanism of dysfunction.
Main Results:
- Stunned segments with normal perfusion show dose-dependent functional augmentation with dobutamine.
- Hibernating myocardium with reduced perfusion typically exhibits a biphasic response to dobutamine, with improvement at low doses and potential ischemia at higher doses.
- Nonviable myocardium (infarction/scarring) may show functional augmentation due to subepicardial stimulation, not indicative of recovery post-revascularization.
Conclusions:
- Accurate differentiation of myocardial dysfunction types (stunning, ischemia, hibernation, nonviable) is essential due to differing prognoses and treatment strategies.
- Dobutamine stress imaging provides valuable insights into the mechanisms of myocardial dysfunction and potential for functional recovery.
- Caution is advised in interpreting imaging results, especially when combinations of these conditions coexist within the same myocardial segments.
Abstract:
Left ventricular function is a major predictor of outcome in patients with coronary artery disease. Acute ischemia, postischemic dysfunction (stunning), myocardial hibernation, or a combination of these 3 are among the reversible forms of myocardial dysfunction. In myocardial stunning, dysfunction occurs despite normal myocardial perfusion, and function recovers spontaneously over time. In acute ischemia and hibernation, there is regional hypoperfusion. Function improves only after revascularization. Evidence of myocardial viability usually relies on the demonstration of uptake of various metabolic tracers, such as thallium (thallous chloride TI 201) or fludeoxyglucose F 18, by dysfunctional myocardium or by the demonstration of contractile reserve in a dysfunctional region. This can be shown as an augmentation of function during the infusion of various sympathomimetic agents. The response of ventricular segments to increasing doses of dobutamine may indicate the underlying mechanism of dysfunction. Stunned segments that have normal perfusion show dose-dependent augmentation of function. If perfusion is reduced as in hibernating myocardium, however, a biphasic response usually occurs: function improves at low doses of dobutamine, whereas higher doses may induce ischemia and, hence, dysfunction. But in patients with severely impaired perfusion, even low doses may cause ischemia. Myocardial regions with subendocardial infarction or diffuse scarring may also have augmented contractility during catecholamine infusion due to stimulation of the subepicardial layers. In these cases, augmentation of function after revascularization is not expected. Because the underlying mechanism, prognosis, and therapy may differ among these conditions, it is crucial to differentiate among dysfunctional myocardial segments that are nonviable and have no potential to regain function, hibernating or ischemic segments in which recovery of function occurs only after revascularization, and myocardial stunning in which function is expected to recover spontaneously. Because combinations of all of these disorders may occur, even in the same segments, caution should be used in interpreting the imaging results.